Table 4.
Study detailsa | Intervention | Outcome measures | Health outcomes resultsb | Downs and Black scorec |
---|---|---|---|---|
Franklin et al.49 Scotland I RCT | N = 92; assessment of SweetTalk, a text-messaging support system to improve self-efficacy and adherence to intensive insulin therapy for youth (10–15 years) with T1DM |
|
|
25 |
Benhamou et al.50 France I RCT | N = 30; randomized crossover trial of telecare for adults with T1DM under continuous subcutaneous insulin infusion, cell phone for transmission of retrospective data, and SMS for immediate feedback |
|
|
23 |
Leu et al.51 USA I RCT | N = 42; T1DM and T2DM; effectiveness of a two-way pager for management of diabetes through medication, blood glucose testing reminders, and exercise reinforcement |
|
|
23 |
Kim and Jeong45 South Korea I RCT | N = 51; diabetes management via nurse SMS by cellular phone and Internet for T2DM patients |
|
|
22 |
Kim and Kim46 South Korea I RCT | N = 34; T2DM; decrease body weight and improve fasting plasma glucose levels through researcher recommendations via cell phone/SMS and Internet (Web site) |
|
|
22 |
Yoon and Kim47 South Korea I RCT | N = 51; educational intervention using cellular phone with SMS and Internet for glycemic control (HbA1c < 7%) in patients with T2DM |
|
|
22 |
Kim48 South Korea I RCT | N = 51; T2DM; weekly blood glucose based optimal recommendations via SMS |
|
|
21 |
Kumar et al.52USA I RCT | N = 40; wireless, portable diabetes management system for youth with T1DM and T2DM; feasibility of system assessed in addition to clinical outcomes |
|
|
21 |
Quinn et al.53 USA I RCT (pilot) | N = 30; T2DM; impact on HbA1c levels via cell-phone-based diabetes management software system (Web-based data analytics and therapy optimization tools); examine health care provider adherence to prescribing guidelines and assessed health care provider's adoption of the technology |
|
|
21 |
Study details are listed according to level of evidence and in order of quality assessment score (Downs and Black). Study levels: I = RCT; II = cohort; III = case control; IV = case series.
↔ indicates no difference in health outcomes; + indicates improvements in health outcomes; and - indicates decline in health outcomes.
Downs and Black score ranges were given corresponding quality levels: excellent (26–28) and good (20–25). Studies that scored either in the fair (15–19) or poor (≤14) ranges were excluded, except where it was the only available evidence.
HPG - 2-hour plasma glucose, HPMG - 2-hour post-meal glucose, HPPT - 2-hour post-prandial test